IP Library Granted Patent US 9,205,050
Granted Patent B2
US 9,205,050 · App. 11/992,347 · Granted Dec 8, 2015

Antibiotic formulations, unit doses, kits and methods

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,205,050
App. No.
11/992,347
Granted
Dec 8, 2015
Kind
B2
Abstract

An aqueous or powder composition includes anti-gram-negative antibiotic or salt thereof being present at an amount ranging from about 100 mg/ml to about 200 mg/ml. Another aqueous or powder composition includes anti-gram-positive antibiotic or salt thereof being present at a concentration ranging from about 0.6 to about 0.9 of the water solubility limit, at 25° C. and 1.0 atmosphere, of the anti-gram-positive antibiotic or salt thereof. Other embodiments include unit doses, kits, and methods.

Claims (10)

1. A method of administering an aerosolized pharmaceutical formulation to a patient who is breathing under the assistance of a ventilator, the method comprising:

providing a unit dose container containing from 5 ml to 6 ml of an aqueous composition for aerosolization comprising:

anti-gram-negative antibiotic or salt thereof being present in the unit dose container at an amount from about 550 mg to about 750 mg and a concentration from about 110 mg/ml to about 150 mg/ml, wherein the anti-gram-negative antibiotic comprises amikacin or salt thereof;

aerosolizing the aqueous composition; and

administering the aerosolized composition into a ventilator circuit in the ventilator at a position between a junction of the inhalation and exhalation lines and an endotracheal tube so that it may be mixed with respiratory gases in the ventilator circuit and delivered to the patient.

2. The method of claim 1 , wherein the aqueous composition consists essentially of the anti-gram-negative antibiotic or salt thereof and water.

3. The method of claim 1 , wherein the amikacin or salt thereof has a potency from about 500 μg/mg to about 1100 μg/mg.

4. The method of claim 1 , wherein the aqueous composition has a pH from about 4 to about 6.

5. The method of claim 1 , wherein the aqueous composition has an osmolality ranging from about 90 mOsmol/kg to about 500 mOsmol/kg.

6. The method of claim 1 , further comprising an additional active agent selected from an anti-inflammatory and a bronchodilator.

Assignments (4)
CONFIRMATORY ASSIGNMENT Recorded Jan 12, 2016
From: CHARAN, CHATAN K.; DWIVEDI, SARVAJNA
To: NEKTAR THERAPEUTICS
Reel/Frame 037486/0200 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 30, 2015
From: NOVARTIS PHARMA AG
To: NEKTAR THERAPEUTICS
Reel/Frame 036927/0187 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 30, 2015
From: NEKTAR THERAPEUTICS
To: BAYER INTELLECTUAL PROPERTY GMBH
Reel/Frame 036927/0214 →
ASSIGNMENT OF PATENT RIGHTS Recorded Jan 7, 2009
From: NEKTAR THERAPEUTICS
To: NOVARTIS PHARMA AG
Reel/Frame 022071/0001 →